Sorry, you need to enable JavaScript to visit this website.
Media Name: rady-johnson300x170px.jpg

Rady Johnson

Chief Compliance, Quality and Risk Officer, Executive Vice President

Rady Johnson is Executive Vice President and Pfizer’s Chief Compliance, Quality and Risk Officer. He has overall responsibility for the company's global compliance program, Regulatory Quality Assurance organization, global security efforts, and Office of the Ombuds.

Since joining Pfizer in 1994, Rady has led the Regulatory Law practice group as well as the Corporate Regulatory and Healthcare Law Audit functions, established the Legal Division’s Global Products Counsel practice group, and served as Senior Vice President and Associate General Counsel for the innovative segments of Pfizer’s Worldwide Biopharmaceuticals Business. Prior to joining the company, Rady was in private practice in Washington, DC, with the law firm of Hogan & Hartson, where he was a member of their food and drug law practice. Previously, Rady was a Certified Public Accountant specializing in the healthcare and hospitality industries for Arthur Anderson. He is a graduate of the University of Richmond and the Georgetown University Law Center.

Rady was recognized by the Ethisphere Institute in 2015 as an Attorney Who Matters for his work in helping to “pioneer a corporate and industry-wide legacy of ethics and integrity.” He chairs the International Federation of Pharmaceutical Manufacturers & Associations' Ethics & Business Integrity Committee, serves on the board of directors of the Pro Bono Partnership and the Citizens Crime Commission of New York City, is an adjunct professor at the University of Connecticut School of Law, and is very active in many local charities and organizations in his hometown of Westport, CT.

ab_headshot_2021_300x170_0.jpg
Dr. Albert Bourla

Chief Executive Officer and Chairman

Bill Carapezzi
Bill Carapezzi

Executive Vice President, Global Business Services and Transformation

dave_denton_300x170.jpg
Dave Denton

Chief Financial Officer and Executive Vice President

Media Name: mikael_dolsten300x170_2019_v3.jpg
Mikael Dolsten, M.D., Ph.D.

Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.

Media Name: lidia_fonseca300x170.jpg
Lidia Fonseca

Chief Digital and Technology Officer, Executive Vice President

angela_hwang_300X170_0.jpg
Angela Hwang

Chief Commercial Officer, President, Global Biopharmaceuticals Business

Media Name: doug_profile_bio_2019_300x170.jpg
Doug Lankler

General Counsel, Executive Vice President

Aamir Malik
Aamir Malik

Chief Business Innovation Officer, Executive Vice President

MikeMcDermott_300x170.jpg
Mike McDermott

Chief Global Supply Officer, Executive Vice President

william_pao_2_300x170.jpg
William Pao, M.D., Ph.D.

Chief Development Officer, Executive Vice President

payal_2021_300x170.jpg
Payal Sahni Becher

Chief People Experience Officer, Executive Vice President

Sally-Susman-2022_300x170_2.jpg
Sally Susman

Chief Corporate Affairs Officer, Executive Vice President